Primary Tumor Volume Is an Important Predictor of Clinical Outcomes Among Patients With Locally Advanced Squamous Cell Cancer of the Head and Neck Treated With Definitive ChemoradiotherapyAnna Strongin, Mohan Suntharalingam, Susannah Yovino et al.|International Journal of Radiation Oncology*Biology*Physics|2011Cited by 116
Oral Lactoferrin Results in T Cell–Dependent Tumor Inhibition of Head and Neck Squamous Cell Carcinoma <i>In vivo</i>Jeffrey S. Wolf, Bert W. O’Malley, Guoyan Li et al.|Clinical Cancer Research|2007Cited by 112
FcγRIIIa polymorphisms and cetuximab induced cytotoxicity in squamous cell carcinoma of the head and neckRodney J. Taylor, Scott E. Strome, Siaw‐Lin Chan et al.|Cancer Immunology Immunotherapy|2008Cited by 101
Impact of early percutaneous endoscopic gastrostomy tube placement on nutritional status and hospitalization in patients with head and neck cancer receiving definitive chemoradiation therapyCharles E. Rutter, Mohan Suntharalingam, Scott E. Strome et al.|Head & Neck|2010Cited by 88
A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN)Dan P. Zandberg, Martin J. Edelman, Sandra Rollins et al.|Cancer Immunology Immunotherapy|2014Cited by 75